Correlation Between Eventide Healthcare and Mfs Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eventide Healthcare and Mfs Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eventide Healthcare and Mfs Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eventide Healthcare Life and Mfs Technology Fund, you can compare the effects of market volatilities on Eventide Healthcare and Mfs Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eventide Healthcare with a short position of Mfs Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eventide Healthcare and Mfs Technology.

Diversification Opportunities for Eventide Healthcare and Mfs Technology

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between Eventide and Mfs is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Eventide Healthcare Life and Mfs Technology Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mfs Technology and Eventide Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eventide Healthcare Life are associated (or correlated) with Mfs Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mfs Technology has no effect on the direction of Eventide Healthcare i.e., Eventide Healthcare and Mfs Technology go up and down completely randomly.

Pair Corralation between Eventide Healthcare and Mfs Technology

Assuming the 90 days horizon Eventide Healthcare is expected to generate 5.52 times less return on investment than Mfs Technology. In addition to that, Eventide Healthcare is 1.63 times more volatile than Mfs Technology Fund. It trades about 0.03 of its total potential returns per unit of risk. Mfs Technology Fund is currently generating about 0.23 per unit of volatility. If you would invest  4,932  in Mfs Technology Fund on September 2, 2024 and sell it today you would earn a total of  252.00  from holding Mfs Technology Fund or generate 5.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Eventide Healthcare Life  vs.  Mfs Technology Fund

 Performance 
       Timeline  
Eventide Healthcare Life 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Eventide Healthcare Life are ranked lower than 1 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong technical indicators, Eventide Healthcare is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Mfs Technology 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Mfs Technology Fund are ranked lower than 13 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak fundamental indicators, Mfs Technology may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Eventide Healthcare and Mfs Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eventide Healthcare and Mfs Technology

The main advantage of trading using opposite Eventide Healthcare and Mfs Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eventide Healthcare position performs unexpectedly, Mfs Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mfs Technology will offset losses from the drop in Mfs Technology's long position.
The idea behind Eventide Healthcare Life and Mfs Technology Fund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device